1 Koskinen L et al. (2009). “Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations.” Immunogenetics. 61(4):247 56.
2 Liu E et al. (2017) “High incidence of celiac disease in a long-term study of adolescents with susceptibility genotypes.” Gastroenterol. 152:1329-1336.
3 Megiorni F et al. (2009) “HLA-DQ and risk gradient for celiac disease.” Hum Immunol 70:55-59.
4 Megiorni F et al. (2012). “HLA-DQA1 and HLA-DQB1 in celiac disease predisposition: practical implications of the HLA molecular typing.” J Biomed Sci 19:88.
5 Monsuur AJ et al. (2008). “Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms.” PLoS One. 3(5):e2270.
6 Nellikkai S et al. (2019) “High prevalence of celiac disease among screened first-degree relatives.” Mayo Clin Proc.94(9):1807-1813.
7 Singh P et al. (2018). “Global prevalence of celiac disease: systematic review and meta-analysis.” Clin Gastroenterol and Hepatol. 16:823-836.
8 Singh P et al. (2015). “Risk of celiac disease in the First- and Second-Degree Relatives of Patients with celiac disease: A Systematic Review and Meta-Analysis.” Am J Gastroenterol. 110(11):1539-48.
9 Taylor AK et al. (2008). “Celiac disease.” [Updated 2015 Sep 17.
10 Tinto N et al. (2015) “High frequency of haplotype HLA-DQ7 in celiac disease patients from South Italy: retrospective evaluation of 5,535 subjects at risk of celiac disease.” PLoS ONE 10(9); e0138324
11 Guidi A et al. (2018) “Celiac disease testing.” College of American Pathologists (CAP) member resources.
12 Pietzak M et al. (2009) “Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.” Clin Gastroenterol Hepatol. 7(9):966-971.
13 Rubio-Tapai A et al. (2013) ACG clinical guidelines: diagnosis and management of celiac disease.” Am J Gastro. 108:656-676.